Electrospun PCL Patch Scaffold for Chronic Tympanic Perforation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current surgical methods for treating chronic tympanic perforation are costly, invasive, and have high recurrence rates, while biocompatible materials like chitosan patches face regulatory hurdles and are ineffective for chronic perforations.

Innovation Solution

A PCL patch tissue regeneration scaffold is developed using electrospinning to create nanofibers in a spindle shape, incorporating growth factors like EGF or IGFBP, which are collected on a collector to provide a biocompatible and effective non-surgical treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical methods are used to treat chronic tympanic perforation, then the treatment can be performed, but the procedure is costly, requires complicated surgery with long operation time, anesthesia, and hospitalization, and has a high recurrence rate of at least 10%

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidsurgical complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention extracts the essential therapeutic function from complex surgical procedures by using a simplified patch application method. The PCL patch with growth factors delivers the necessary treatment without requiring complicated surgery, anesthesia, or hospitalization, thus removing unnecessary complexity while maintaining treatment effectiveness.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The PCL patch is designed as a disposable, cost-effective treatment device that can be easily applied and does not require expensive surgical infrastructure. The patch provides sufficient treatment duration for tissue regeneration without needing long-term medical infrastructure support, reducing overall treatment costs.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of manufacture

If paper patch technique is used for acute tympanic perforation, then small perforations can be treated, but the method is not effective for chronic tympanic perforation and non-biocompatible materials cause inflammation with success rate less than 10%

Engineering Contradiction:
Improvetreatment simplicityVSAvoidtreatment success rate
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention changes the material parameters from non-biocompatible paper to biocompatible PCL polymer, and incorporates growth factors to change the biological activity parameters. This transformation maintains the simplicity of patch application while dramatically improving treatment success rate for chronic perforations by enabling active tissue regeneration.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The PCL patch combines biocompatible polymer material with embedded growth factors to create a composite structure that provides both mechanical support and biological activity. This composite approach maintains ease of application like paper patches while achieving high success rates through enhanced biocompatibility and active regeneration promotion.

Inventive Principle:
Principle #40Composite materials

3Reliability

If chitosan patches containing growth factors are used, then high cure rate is achieved in animal models, but the material has not been approved by FDA for clinical practice

Engineering Contradiction:
Improvecure rateVSAvoidclinical applicability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The PCL patch uses a polymer material that is already FDA-approved for medical use, replacing the unapproved chitosan material. The patch is designed as a disposable device with sufficient longevity to achieve tissue regeneration, maintaining high cure rates while ensuring regulatory approval and clinical applicability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention changes the base material from chitosan to PCL polymer while maintaining the growth factor incorporation strategy. This parameter change in material composition preserves the high cure rate mechanism while improving regulatory status and clinical manufacturability, as PCL has established FDA approval history.

Inventive Principle:
Principle #35Parameter changes

4Manufacturing precision

If electrospinning is used to produce nanofibers, then uniform and continuous nanofibers with various properties can be created, but there is no method for manufacturing a spindle-shaped tissue regeneration scaffold

Engineering Contradiction:
Improvenanofiber uniformityVSAvoidscaffold shape variety
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The invention introduces asymmetric spindle-shaped patterns into the electrospun nanofiber scaffold by controlling the collector rotation during manufacturing. This asymmetric shape design enhances cell morphology control and tissue regeneration guidance while maintaining the uniformity and continuity of nanofiber structure through precise electrospinning parameters.

Inventive Principle:
Principle #4Asymmetry

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The PCL patch reduces the need for surgery and enhances healing by promoting cell proliferation and tissue regeneration, offering a high recovery rate for chronic tympanic perforation.

Implementation Method 1

Electrospinning is one of the easiest methods to produce nanofibers, which can produce nanofibers that are uniform, continuous and can exhibit various properties depending on the composition ratio

Methodology Applied
Scientific EffectElectrospinning: Electrohydrodynamics

Data Source

PatentUS12622999B2PCL patch tissue regeneration scaffold and method for manufacturing same
Publication Date: 2026.05.12 AJOU UNIV IND ACADEMIC COOP FOUND
  • US12622999B2 patent drawing
  • US12622999B2 patent drawing
  • US12622999B2 patent drawing

AI summary

Disclosed is a method of treating a chronic tympanic perforation with a PCL patch tissue regeneration scaffold comprising preparing solution by adding polycaprolactone (PCL) and an acid to an organic solvent; preparing an electrospinning solution by adding a growth factor to the solution and stirring; collecting nanofibers arranged in a spindle shape on a collector by connecting the electrospinning solution prepared to a syringe pump and operating the electrospinning device; and administering the PCL patch tissue regeneration scaffold to a subject.